Literature DB >> 17044032

Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes.

Yangzhou Du1, Lauren D Lercher, Renping Zhou, Cheryl F Dreyfus.   

Abstract

Previous studies indicate that brain-derived neurotrophic factor (BDNF), through the mediation of the trkB receptor, modulates the expression of differentiated traits in basal forebrain (BF) oligodendrocytes (OLGs). Specifically, BDNF up-regulates the expression of myelin basic protein (MBP), proteolipid protein (PLP), and myelin associated glycoprotein (MAG; Du et al. [2006] Mol. Cell. Neurosci. 31:366-375). However, the signaling cascades mediating the effects of BDNF have not been defined. The current study employs biochemical and molecular biological approaches to examine the involvements of the mitogen-activated protein kinase (MAPK) pathway, the phosphatidylinositol-3 kinase (PI3K) pathway, and the phospholipase C-gamma (PLC-gamma) pathway. Our results indicate that, in BF OLGs, BDNF activates the MAPK pathway and the PLC-gamma pathway but not the PI3K-Akt signaling cascade. By using specific inhibitors and mutated dominant negative or constitutively active forms of MAPK kinase, we demonstrate that the MAPK pathway is mediating the effects of BDNF on expression of differentiated traits in BF OLGs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044032     DOI: 10.1002/jnr.21080

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  34 in total

1.  Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation.

Authors:  Hebe M Guardiola-Diaz; Akihiro Ishii; Rashmi Bansal
Journal:  Glia       Date:  2011-12-05       Impact factor: 7.452

Review 2.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 3.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

4.  Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain.

Authors:  Kelly Michel; Tianna Zhao; Molly Karl; Katherine Lewis; Sharyl L Fyffe-Maricich
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

5.  Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment.

Authors:  Anna C Geraghty; Erin M Gibson; Reem A Ghanem; Jacob J Greene; Alfonso Ocampo; Andrea K Goldstein; Lijun Ni; Tao Yang; Rebecca M Marton; Sergiu P Paşca; Michael E Greenberg; Frank M Longo; Michelle Monje
Journal:  Neuron       Date:  2019-05-20       Impact factor: 17.173

Review 6.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

7.  Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth.

Authors:  Cristina A Ghiani; Zhe Ying; Jean de Vellis; Fernando Gomez-Pinilla
Journal:  Glia       Date:  2007-07       Impact factor: 7.452

8.  ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.

Authors:  Akihiro Ishii; Sharyl L Fyffe-Maricich; Miki Furusho; Robert H Miller; Rashmi Bansal
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

9.  Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion.

Authors:  Akihiro Ishii; Miki Furusho; Rashmi Bansal
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

10.  BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain.

Authors:  Melissa W Vondran; Patricia Clinton-Luke; Jean Z Honeywell; Cheryl F Dreyfus
Journal:  Glia       Date:  2010-05       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.